Galdu-irabazien kontua
ALBERTSONS COMPANIES, INC.
ACI
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Feb 28, 2025 2024 FY | Feb 29, 2024 2023 FY | Feb 28, 2023 2022 FY | Feb 28, 2022 2021 FY | Feb 28, 2021 2020 FY | Feb 29, 2020 2019 FY | Feb 28, 2019 2018 FY | Feb 28, 2018 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
80,390.90 | 79,237.70 | 77,649.70 | 71,887.00 | 69,690.40 | 62,455.10 | 60,534.50 | 59,924.60 |
|
Diru-sarreren kostua
|
58,135.30 | 57,192.00 | 55,894.10 | 51,164.60 | 49,275.90 | 44,860.90 | 43,639.90 | 43,563.50 |
|
Irabazi gordina
|
22,255.60 | 22,045.70 | 21,755.60 | 20,722.40 | 20,414.50 | 17,594.20 | 16,894.60 | 16,361.10 |
|
Ustiapen-gastuak
|
20,613.70 | 19,932.90 | 19,596.00 | 18,300.50 | 18,835.80 | 16,641.90 | 16,107.30 | 16,223.70 |
|
Ikerketa eta garapena
|
- | - | - | - | - | - | - | - |
|
Salmentak, orokorrak eta administratiboak
|
20,613.70 | 19,932.90 | 19,596.00 | 18,300.50 | 18,835.80 | 16,641.90 | 16,107.30 | 16,223.70 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
1,641.90 | 2,112.80 | 2,159.60 | 2,421.90 | 1,578.70 | 952.30 | 787.30 | 137.40 |
|
Ez-ustiapeneko diru-sarrerak
|
512.20 | - | - | - | - | - | 735.10 | 1,054.90 |
|
Interesen diru-sarrerak
|
- | - | - | - | - | - | - | - |
|
Interesen gastuak
|
414.80 | 446.90 | 404.90 | 400.00 | 463.40 | 565.30 | 698.30 | 701.50 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
43.40 | 12.20 | 11.80 | 63.50 | 134.70 | -28.50 | 104.40 | -42.50 |
|
Zerga aurreko irabazia
|
1,129.70 | - | - | - | 1,128.70 | 599.20 | 52.20 | -917.50 |
|
Zerga-gastua
|
171.10 | 293.00 | 422.00 | 479.90 | 278.50 | 132.80 | -78.90 | -963.80 |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - |
|
Irabazi garbia
|
958.60 | 1,296.00 | 1,513.50 | 1,619.60 | 850.20 | 466.40 | 131.10 | 46.30 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Feb 28, 2025 2024 FY | Feb 29, 2024 2023 FY | Feb 28, 2023 2022 FY | Feb 28, 2022 2021 FY | Feb 28, 2021 2020 FY | Feb 29, 2020 2019 FY | Feb 28, 2019 2018 FY | Feb 28, 2018 2017 FY |
|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - |
|
EBITDA
|
3,459.80 | 3,891.80 | 3,966.70 | 4,103.20 | 1,578.70 | 952.30 | 787.30 | 137.40 |
|
Akzioko irabazia (oinarrizkoa)
|
1.65 | 2.25 | 2.29 | 2.73 | 1.53 | 1.67 | - | - |
|
EPS diluitua
|
1.64 | 2.23 | 2.27 | 2.70 | 1.47 | 1.67 | - | - |
|
Akzioen batez besteko haztatua
|
580.10 | 575.40 | 529.00 | 469.60 | 500.30 | 279.60 | - | - |
|
Akzioen batez besteko haztatu diluitua
|
583.80 | 581.10 | 534.00 | 475.30 | 578.10 | 280.10 | - | - |
|
Irabazi globala
|
965.30 | 1,314.70 | 1,513.80 | 1,625.10 | 1,032.20 | 256.60 | 31.30 | 250.20 |